BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31031041)

  • 1. Adjuvant Therapy for Urothelial and Renal Cell Carcinoma.
    Patel HD; Kates M; Allaf ME
    Eur Urol Focus; 2020 Jan; 6(1):3-6. PubMed ID: 31031041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis.
    Mori K; Yanagisawa T; Fukuokaya W; Iwatani K; Matsukawa A; Katayama S; Pradere B; Laukhtina E; Rajwa P; Moschini M; Albisinni S; Krajewski W; Cimadamore A; Del Giudice F; Teoh J; Urabe F; Kimura S; Murakami M; Tsuzuki S; Miki J; Miki K; Shariat SF; Kimura T;
    Int J Urol; 2024 Jan; 31(1):25-31. PubMed ID: 37840031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers.
    Apolo AB; Msaouel P; Niglio S; Simon N; Chandran E; Maskens D; Perez G; Ballman KV; Weinstock C
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-16. PubMed ID: 35609225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
    Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
    J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma.
    Tabayoyong W; Li R; Gao J; Kamat A
    Urol Clin North Am; 2018 May; 45(2):155-167. PubMed ID: 29650132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker-Oriented Therapy in Bladder and Renal Cancer.
    Scholtes MP; Alberts AR; Iflé IG; Verhagen PCMS; van der Veldt AAM; Zuiverloon TCM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant and adjuvant treatment of renal cell carcinoma.
    Thillai K; Allan S; Powles T; Rudman S; Chowdhury S
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):765-76. PubMed ID: 22716493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
    Lenis AT; Donin NM; Johnson DC; Faiena I; Salmasi A; Drakaki A; Belldegrun A; Pantuck A; Chamie K
    J Urol; 2018 Jan; 199(1):43-52. PubMed ID: 28479237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy in renal cell carcinoma.
    Massari F; Di Nunno V; Ciccarese C; Graham J; Porta C; Comito F; Cubelli M; Iacovelli R; Heng DYC
    Cancer Treat Rev; 2017 Nov; 60():152-157. PubMed ID: 28992528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
    Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM
    J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
    Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
    World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Achkar T; Parikh RA
    Urol Clin North Am; 2018 May; 45(2):257-266. PubMed ID: 29650141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
    Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
    J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
    Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
    J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Teo MY; Rosenberg JE
    Urol Clin North Am; 2018 May; 45(2):287-295. PubMed ID: 29650143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature.
    Bandini M; Smith A; Marchioni M; Pompe RS; Martel TF; Cindolo L; Montorsi F; Shariat SF; Briganti A; Kapoor A; Capitanio U; Karakiewicz PI
    Clin Genitourin Cancer; 2018 Jun; 16(3):176-183. PubMed ID: 29449091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials.
    Bex A; Jonasch E; Kirkali Z; Mejean A; Mulders P; Oudard S; Patard JJ; Powles T; van Poppel H; Wood CG
    Eur Urol; 2010 Dec; 58(6):819-28. PubMed ID: 20828919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant treatment for renal cell carcinoma: in the long run will we get the same answers?
    Grassi P; Verzoni E; Procopio G
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):803-4. PubMed ID: 27322839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.